Literature DB >> 17881175

Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions.

Michael Mitterberger1, Alexandre Pelzer, Daniela Colleselli, Georg Bartsch, Hannes Strasser, Leo Pallwein, Friedrich Aigner, Johann Gradl, Ferdinand Frauscher.   

Abstract

PURPOSE OF REVIEW: Conventional ultrasonography of both, kidney and prostate, is limited due to the poor contrast of B-mode imaging for parenchymal disease and limited sensitivity of colour Doppler for the detection of capillaries and deep pedicular vessels. Contrast-enhanced ultrasound (CEUS) overcomes these limitations. RECENT
FINDINGS: CEUS investigates the blood flow of the prostate, allows for prostate cancer visualization and for targeted biopsies. Comparisons between systematic and CEUS-targeted biopsies have shown that the targeted approach detects more cancers with a lower number of biopsy cores and with higher Gleason scores compared with the systematic approach. Also the kidney offers promising applications as CEUS improves the detection of abnormal microvascular and macrovascular disorders.
SUMMARY: In recent literature CEUS has shown its value for diagnosis of both, prostate cancer and kidney lesions. This paper describes recent improvements and future perspectives of CEUS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881175     DOI: 10.1016/j.ejrad.2007.07.027

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  16 in total

1.  [The impact of ultrasound in urology].

Authors:  G Schöppler; J Heinzelbecker; H J Michaely; D Dinter; D-A Clevert; A E Pelzer
Journal:  Urologe A       Date:  2012-01       Impact factor: 0.639

2.  Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.

Authors:  Michael Josef Mitterberger; Friedrich Aigner; Wolfgang Horninger; Hanno Ulmer; Silvio Cavuto; Ethan J Halpern; Ferdinand Frauscher
Journal:  Eur Radiol       Date:  2010-06-23       Impact factor: 5.315

3.  Synthesis of nanobubbles for improved ultrasound tumor-imaging applications.

Authors:  Juanjuan Zhang; Lunshou Wei; Yilin Zhao
Journal:  3 Biotech       Date:  2019-12-09       Impact factor: 2.406

4.  2-tier in-plane motion correction and out-of-plane motion filtering for contrast-enhanced ultrasound.

Authors:  Casey N Ta; Mohammad Eghtedari; Robert F Mattrey; Yuko Kono; Andrew C Kummel
Journal:  Invest Radiol       Date:  2014-11       Impact factor: 6.016

5.  [Cross-sectional imaging evaluation of renal masses].

Authors:  P Nuhn; A Sterzik; C G Stief; M Staehler; M D'Anastasi
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

6.  Integrated processing of contrast pulse sequencing ultrasound imaging for enhanced active contrast of hollow gas filled silica nanoshells and microshells.

Authors:  Casey N Ta; Alexander Liberman; H Paul Martinez; Christopher V Barback; Robert F Mattrey; Sarah L Blair; William C Trogler; Andrew C Kummel; Zhe Wu
Journal:  J Vac Sci Technol B Nanotechnol Microelectron       Date:  2012-03-23

7.  Automating tumor classification with pixel-by-pixel contrast-enhanced ultrasound perfusion kinetics.

Authors:  Casey N Ta; Yuko Kono; Christopher V Barback; Robert F Mattrey; Andrew C Kummel
Journal:  J Vac Sci Technol B Nanotechnol Microelectron       Date:  2012-03-22

Review 8.  Ultrasound of the prostate.

Authors:  Michael Mitterberger; Wolfgang Horninger; Friedrich Aigner; Germar M Pinggera; Ilona Steppan; Peter Rehder; Ferdinand Frauscher
Journal:  Cancer Imaging       Date:  2010-03-03       Impact factor: 3.909

9.  Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.

Authors:  M Bertolotto; E Trincia; R Zappetti; R Bernich; G Savoca; M A Cova
Journal:  Radiol Med       Date:  2009-08-20       Impact factor: 3.469

Review 10.  A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck
Journal:  Int Urol Nephrol       Date:  2009-06-03       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.